Pivekimab sunirine | m-entrepreneurship.com

Product Name :
Pivekimab sunirine

Search keywords :
Pivekimab

drugId :
null

Target Vo:
Interleukin-3 receptor subunit alpha

Target Vo Short Name :
IL3RA

Moa_Name:
Alkylating agents

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunogen Inc

Active Company_Name :
Immunogen Inc

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fianlimab Epigenetic Reader Domain
eIF4A1 (YP6015) Mouse mAb web
p53 (acetyl K370)Antibody: p53 (acetyl K370)Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to p53(acetyl K370). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts